MassDevice

Sonorous Neurovascular earns FDA breakthrough mark for novel stent

BosSTENT is a novel braided, self-expanding stent that differs from traditional mesh stents intended to treat pulsatile ...
Endovascular Today

Sonorous Neurovascular BosSTENT for Pulsatile Tinnitus Receives FDA Breakthrough Device Designation

Sonorous Neurovascular announced that the FDA has granted Breakthrough Device designation for its BosSTENT, a braided, ...

Sonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT(TM), First Braided Self-Expanding Cerebral Venous Stent, to Treat Debilitating Pulsatile Tinnitus

Sonorous Neurovascular is advancing clinical trials and regulatory pathways to bring the BosSTENT (TM) to patients in the United States and beyond.
Mena FN

Serenity Medical Announces Clinical Publication Of First Prospective Multicenter Trial Of The River™ Stent, A Novel Venous Sinus Stent For Treating Idiopathic Intracranial ...

(MENAFN- GlobeNewsWire - Nasdaq) Publication in the Journal of NeuroInterventional Surgery Reports Outcomes for Treatment of IIH Patients Who Are Refractory or Intolerant to Medications HARRISON, N.Y.
bangaloremirror.indiatimes

Rare brain condition treated with venous stenting

Persistent headaches and vision loss led doctors to diagnose drug-resistant intracranial hypertension in Bengaluru woman, successfully treated through minimally invasive venous stenting A 26-year-old ...
WGNO

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial ...

HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company dedicated to the treatment of venous sinus stenosis, today announced the ...